by Sandeep Gupta | Oct 17, 2019 | Mental Health, Neurological, Publication
Abstract Authors: Daisy Ng-Mak, Andrew Messali, Ahong Huang, Li Wang, Antony Loebel This study compared the risk of hospitalization among adults with schizophrenia being treated with equivalent dose ranges of lurasidone versus aripiprazole, olanzapine, quetiapine, or...
by Sandeep Gupta | May 20, 2019 | Mental Health, Neurological, Publication
Abstract Authors: Shah A, Xie L, Kariburyo F, Zhang Q, Gore M Introduction: Long-acting injectable (LAI) antipsychotic use may reduce healthcare resource utilization compared with oral antipsychotic use by improving adherence and reducing dosing frequency. Our goal...
by Sandeep Gupta | May 19, 2019 | Mental Health, Neurological, Publication
Abstract Authors: Huang A, Amos TB, Joshi K, Wang L, Nash A Background: Schizophrenia is a serious public health problem that affects ∼1% of the US population. Aims: To examine treatment patterns and evaluate healthcare resource utilization (HRU) and costs...
by Sandeep Gupta | May 18, 2019 | Mental Health, Publication
Abstract Authors: Pesa JA, Doshi D, Wang L, Yuce H, Baser O. Objective: To compare all-cause health care utilization and costs between patients with schizophrenia treated with once monthly paliperidone palmitate (PP1M; Invega Sustenna) and atypical oral antipsychotic...
by Sandeep Gupta | May 16, 2019 | Mental Health, Publication
Abstract Authors: Baser O, Xie L, Pesa J, Durkin M. Objective: This study aimed to compare real world healthcare costs and resource utilization between patients with schizophrenia treated with paliperidone palmitate long-acting injection (PP) and oral atypical...
by Sandeep Gupta | May 14, 2019 | Mental Health, Pain / Palliative, Publication
Abstract Authors: Baser O, Xie L, Mardekian J, Schaaf D, Wang L, Joshi AV. Objective: Evaluate prevalence and risk-adjusted healthcare costs of diagnosed opioid abuse in the national Veterans Health Administration (VHA). Costs were compared between patients with...
